Gottsegen National Cardiovascular Center — Budapest

Public research footprint of Gottsegen National Cardiovascular Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Heart Failure · Pulmonary Arterial Hypertension · Diabetes Mellitus, Type 2 · Symptomatic Severe Aortic Stenosis

Recently updated registry entries

NCT07037446 — A Multicenter, International, Prospective and Retrospective, Follow-up Registry to… (Enrolling By Invitation)
NCT07064473 — EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… (Recruiting)
NCT06935370 — A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gottsegen National Cardiovascular Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.